# Traditional Chinese Medicine as Preventive Method for Osteoporosis Induced by Adjuvant Endocrine Therapy

> **NCT02455154** · PHASE2 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 278 (actual)

## Conditions studied

- Breast Cancer
- Osteoporosis

## Interventions

- **DRUG:** Letrozole
- **DRUG:** Zhongyaofufang
- **DRUG:** Xianlinggubao

## Key facts

- **NCT ID:** NCT02455154
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2019-02
- **Final completion:** 2019-09
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2020-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02455154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02455154, "Traditional Chinese Medicine as Preventive Method for Osteoporosis Induced by Adjuvant Endocrine Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02455154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*